 |
|
 |
|
 |
|
| Oncology Associates, a division of RC Medical, Inc. is a group purchasing organization designed to offer practice management services and exclusive product agreements with discount pricing benefits to private practice physicians throughout the United States. |
|
|
|
|
|
 |
 |
|
|
 |
|
|
 |
 |
| Amgen Contract Update |
 |
| Oncology Associates' agreement with Amgen for purchases of Aranesp® (darbepoetin alfa), Neulasta® (pegfilgrastim) and Neupogen® (filgrastim) has recently been updated. |
|
| Click here to learn more (pdf) |
|
|
|
New Agreement with Merck:
Emend for Injection |
|
| Oncology Associates is pleased to announce a new agreement with Merck for Emend for Injection (fosaprepitant dimeglumine). The agreement will run from July 1, 2008 through June 30, 2010. |
|
| Click here to learn more (pdf) |
|
|
|
| Eloxatin Now Available in 200 MG Vial |
|
| More convenience, efficiency and safety with single vials of Eloxatin. |
|
| Click here to learn more (pdf) |
|
 |
 |
|
| Click Here to Read Archived Contract Updates |
|
|
|
|
|
